Literature DB >> 26215309

Cardiac Extracellular Matrix Scaffold Generated Using Sarcomeric Disassembly and Antigen Removal.

Angela Papalamprou1, Leigh G Griffiths2.   

Abstract

Xenogeneic cardiac extracellular matrix (cECM) scaffolds for reconstructive cardiac surgery applications have potential to overcome the limitations of current clinically utilized patch materials. A potentially ideal cECM scaffold would be immunologically acceptable while preserving the native cECM niche. Production of such a scaffold necessitates removal of cellular and antigenic components from cardiac tissue while preserving cECM structure/function properties. Existing decellularization methodologies predominantly utilize denaturing detergents which might irreversibly alter cECM material properties. To overcome potential deficiencies of current approaches, the effect of sarcomere relaxation and disassembly on resultant cECM scaffold cellularity was investigated. Additionally, the ability of sequential differential protein solubilization (antigen removal-AR) to reduce cECM scaffold antigenicity was examined. Sarcomeric relaxation and disassembly were necessary to achieve scaffold acellularity. All groups in which AR was employed displayed statistically significant decreases in residual antigenicity regardless of their degree of acellularity. AR combined with sarcomeric disassembly preserved structural, biochemical, mechanical and recellularization properties of the cECM scaffold. However, sodium dodecyl sulfate significantly altered cECM properties. This study demonstrates the importance of solubilizing cellular elements and antigenic components in a stepwise manner for production of a potentially ideal cECM scaffold and may have implications for future tissue engineering and regenerative medicine applications.

Entities:  

Keywords:  Antigenicity; Cardiac tissue engineering; Decellularization; Extracellular matrix scaffold; Xenogeneic tissues

Mesh:

Substances:

Year:  2015        PMID: 26215309     DOI: 10.1007/s10439-015-1404-6

Source DB:  PubMed          Journal:  Ann Biomed Eng        ISSN: 0090-6964            Impact factor:   3.934


  4 in total

Review 1.  Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Tissue Eng Part B Rev       Date:  2019-11-27       Impact factor: 6.389

2.  Antigen removal process preserves function of small diameter venous valved conduits, whereas SDS-decellularization results in significant valvular insufficiency.

Authors:  Manuela Lopera Higuita; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2020-03-07       Impact factor: 8.947

3.  Interindividual heterogeneity affects the outcome of human cardiac tissue decellularization.

Authors:  Miguel F Tenreiro; Henrique V Almeida; Tomás Calmeiro; Elvira Fortunato; Lino Ferreira; Paula M Alves; Margarida Serra
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

4.  Tissue engineered bovine saphenous vein extracellular matrix scaffolds produced via antigen removal achieve high in vivo patency rates.

Authors:  Manuela Lopera Higuita; Juan F Lopera Giraldo; Tiffany L Sarrafian; Leigh G Griffiths
Journal:  Acta Biomater       Date:  2021-06-27       Impact factor: 10.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.